Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1303281 | 0.86 | — | — | |
| SCHEMBL2705361 | 0.83 | L3MBTL1 (0.32) | — | |
| SCHEMBL16752678 | 0.81 | L3MBTL1 (0.36) | — | |
| SCHEMBL4785199 | 0.74 | ALDH1A1 (0.30) | — | |
| SCHEMBL4681202 | 0.74 | ALDH1A1 (0.38) | — | |
| SCHEMBL4671779 | 0.73 | — | — | |
| SCHEMBL1656311 | 0.73 | — | — | |
| SCHEMBL6050117 | 0.72 | L3MBTL1 (0.30) | — | |
| SCHEMBL416603 | 0.72 | L3MBTL1 (0.30) | — | |
| SCHEMBL1128201 | 0.72 | L3MBTL1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7776896-B2 | 5-cyano-prostacyclin derivatives as agents for the treatment of influenza a viral infection | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-08-17 | — | — | US | disclosed |
| EP-2142524-A1 | NOVEL 5-CYANO-PROSTACYCLIN DERIVATIVES AND THEIR USE AS AGENTS FOR THE TREATMENT OF INFLUENZA A VIRAL INFECTION | Bayer Schering Pharma Aktiengesellschaft (DE) | 2010-01-13 | — | — | EP | disclosed |
| EP-1988087-A1 | Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of autoimmune diseases | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-11-05 | — | — | EP | disclosed |
| US-20080242714-A1 | Novel 5-cyano-prostacyclin derivatives as agents for the treatment of influenza a viral infection | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-10-02 | — | — | US | disclosed |
| US-20080242713-A1 | Novel 5-cyano-prostacyclin derivatives as agents for the treatment of autoimmune diseases | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-10-02 | — | — | US | disclosed |
| WO-2008116670-A1 | NOVEL 5-CYANO-PROSTACYCLIN DERIVATIVES AND THEIR USE AS AGENTS FOR THE TREATMENT OF AUTOIMMUNE DISEASES | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-10-02 | — | — | WO | disclosed |
| WO-2008116669-A1 | NOVEL 5-CYANO-PROSTACYCLIN DERIVATIVES AND THEIR USE AS AGENTS FOR THE TREATMENT OF INFLUENZA A VIRAL INFECTION | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080242713-A1 | Novel 5-cyano-prostacyclin derivatives as agents for the treatment of autoimmune diseases | PTGIR, PTGIS, PTGER1 | HIF1A 1972/4885EPAS1 344/4885 |
| US-20080242714-A1 | Novel 5-cyano-prostacyclin derivatives as agents for the treatment of influenza a viral infection | PTGIR, PTGER1, PTGIS | HIF1A 425/4885EPAS1 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.